Skip to main content
Caplight Logo









StemCardia

StemCardia

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://stemcardia.com/

Company Overview

StemCardia is a biotechnology company that develops cellular and genetic therapies to address heart failure.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cell therapyregenerative medicineheart failure therapycardiac repairinduced pluripotent stem cellsiPSCcardiomyocyte therapyoff-the-shelf cell therapystem cell therapycardiac remuscularizationallogeneic cell therapyregen medcardiac gene therapyclinical-stage biotechbiotherapeutic delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StemCardia Comparables

Compare StemCardia with similar companies based on industry and business-model similarity.

StemCardia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Heartseed
86%
Help Therapeutics
85%
BioCardia Inc
74%

StemCardia Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

StemCardia Filings

Explore SEC and related filing metadata, where available.

StemCardia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about StemCardia's valuation, stock price, and market status.

Is StemCardia a public or private company?

StemCardia is a private company.

What is the current stock price of StemCardia?

StemCardia is a private company with no public stock price. No recent secondary market data is available.

How much is StemCardia worth (valuation)?

Valuation information for StemCardia is not publicly available.

Can I buy StemCardia stock?

StemCardia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was StemCardia's last funding round?

Funding round information for StemCardia is not publicly available.

Who are the main investors in StemCardia?

Investor information for StemCardia is not publicly disclosed.

Will StemCardia IPO soon?

No public IPO plans have been announced for StemCardia.

How can I track StemCardia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StemCardia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?